INSIGHTS ON PHARMACEUTICAL PACKAGING

  • A Robust Extractables Data Package Helps Drive Patient Safety
    10/1/2024

    Complex drug product formulations are more common, so it is imperative to have a deeper knowledge of extractables to understand risks associated with potential interactions between packaging and product.

  • Sachet Packaging Solutions
    3/4/2025

    Discover versatile, high-quality sachets for manufacturers and consumers with an ideal fill weight of 2 grams and above that is suitable for food or liquid formulas.

  • Why Compounding Pharma Manufacturers Should Evaluate BFS Systems
    12/5/2024

    Discover how BFS technology offers compounding pharmacies and 503B facilities enhanced sterility, reduced errors, cost savings, and superior product integrity for aseptic pharmaceutical manufacturing.

  • Blister Solutions
    3/4/2025

    With over 6,000 tooling parts and an in-house machining center to ensure precision, explore this versatile blister service that provides both Thermoformed and Cold-Formed solutions.

  • New Standards For Elastomeric Components In Sterile Packaging
    1/20/2026

    USP’s new elastomeric packaging standards shift testing to full system‑level evaluation, strengthen integrity and usability expectations, and place compliance responsibility on drug developers.

PHARMACEUTICAL PACKAGING SOLUTIONS

  • Decades of experience in production technologies, quality control and knowledge of the regulatory environment result in high-quality drug delivery devices that are fully optimized to perform as a system.

  • Medicines are highly sensitive to primary packaging components, which can affect compatibility with container closure systems. Discover Alba® syringes, designed for sensitive biologics, including highly concentrated drugs vulnerable to silicone interaction and ophthalmic medications.

  • Streamline workflows with reliable results with ready-to-use chemical solutions. Custom formulations and flexible packaging save preparation time in complex lab applications.

  • USP <382> testing assesses packaging integrity, safety, and performance using deterministic CCIT and functional evaluations to support validation and regulatory submissions.

  • The pharmaceutical industry continues to bring breakthroughs in the field of new drugs and drug delivery systems amidst the increased scrutiny of the regulators. The packaging acts as the primary sterile barrier in drug delivery systems that safeguard the drug product through its life cycle. The efficiency of the primary sterile barrier and the functional components are of utmost importance to patient safety.